EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bone health in patients with inflammatory bowel disease

Andrea S Kreienbuehl, Gerhard Rogler, Burri Emanuel, Luc Biedermann, Christian Meier, Pascal Juillerat, Sophie Restellini, Peter Hruz, Stefan R Vavricka, Daniel Aeberli, Frank Seibold

Swiss Medical Weekly · 2024

DOI: 10.57187/s.3407 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Swiss Medical Weekly, 2024. Verfasst von Andrea S Kreienbuehl und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Osteoporosis, Bone Density, Bone Diseases, Metabolic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with inflammatory bowel disease (IBD) are prone to reduced bone mineral density and elevated overall fracture risk. Osteopenia affects up to 40% of patients with IBD (high regional variability). Besides disease activity, IBD specialists must consider possible side effects of medication and the presence of associated diseases and extraintestinal manifestations. Osteopenia and osteoporosis remain frequent problems in patients with IBD and are often underestimated because of widely differing screening and treatment practices. Malnutrition, chronic intestinal inflammation and corticosteroid intake are the major pathophysiological factors contributing to osteoporosis. Patients with IBD are screened for osteoporosis using dual-energy X-ray absorptiometry (DXA), which is recommended for all patients with a prolonged disease course of more than three months, with repeated corticosteroid administration, aged >40 years with a high FRAX risk score or aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesOsteoporosisBone DensityBone Diseases, MetabolicAbsorptiometry, PhotonHumansRisk FactorsVitamin DBone Density Conservation AgentsDiphosphonates

Substanzen

Vitamin DBone Density Conservation AgentsDiphosphonates

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Gastroenterology and Hepatology, University Medical Clinic, Kantonsspital Baselland, Liestal, Switzerland.
  • Crohn's and Colitis Center, Gastroenterologie Beaulieu, Lausanne, Switzerland.
  • Gastroenterology, Clinic for Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Inflammatory Bowel Disease Center, Division of Gastroenterology, Hôpital de la Tour, Geneva, Switzerland.
  • Faculty of Medicine, University of Geneva, Switzerland.

Zitieren

APA

Kreienbuehl, A. S., Rogler, G., Emanuel, B., Biedermann, L., Meier, C., Juillerat, P., Restellini, S., Hruz, P., Vavricka, S. R., Aeberli, D., & Seibold, F. (2024). Bone health in patients with inflammatory bowel disease. Swiss Medical Weekly. https://doi.org/10.57187/s.3407

Vancouver

Kreienbuehl AS, Rogler G, Emanuel B, Biedermann L, Meier C, Juillerat P, et al. Bone health in patients with inflammatory bowel disease. Swiss Medical Weekly. 2024. doi:10.57187/s.3407

BibTeX
@article{Kreienbuehl2024,
  author = {Kreienbuehl, Andrea S and Rogler, Gerhard and Emanuel, Burri and Biedermann, Luc and Meier, Christian and Juillerat, Pascal and Restellini, Sophie and Hruz, Peter and Vavricka, Stefan R and Aeberli, Daniel and Seibold, Frank},
  title = {Bone health in patients with inflammatory bowel disease},
  journal = {Swiss Medical Weekly},
  year = {2024},
  doi = {10.57187/s.3407}
}
Kostenlos starten →